Inhibitory activity of fenoterol on Dermatophagoides-, Parietaria-, tetanus-toxoid-, and Candida albicans-stimulated blood mononuclear cells: Differences in β2-adrenoreceptor stimulation but not in cell apoptosis

Journal of Asthma

Volumn 37, Issue 3, 2000, Pages 281-290

  Silvestri, Michela ^b   Oddera, Susanna ^b   Scarso, Lucia ^b   Pistoia, Vito ^a   Tasso, Paola ^a   Rossi, Giovanni A ^a  

^a G GASLINI INSTITUTE   (Italy)

^b G Gaslini Institute ^*

Author keywords

Allergens; Apoptosis; Cyclic AMP; Fenoterol; Mononuclear cells

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; FENOTEROL; TETANUS TOXOID;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATOPY; BETA ADRENERGIC STIMULATION; CANDIDA ALBICANS; CELL CULTURE; DERMATOPHAGOIDES; DRUG ACTIVITY; HUMAN; MONONUCLEAR CELL; NONHUMAN;

EID: 0034025355     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770900009055451     Document Type: Article

References (36)

1. Barnes BJ: Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 152:828 (1995).
2. Nelson HS: β-adrenergic bronchodilators. N Engl J Med 333:499 (1995).
3. Butchers PR, Vardley CJ, Johnson M: Salmeterol: a potent and long-acting inhibitor of inflammatory release from human lung. Br J Pharmacol 104:672 (1991).
4. Yukawa T, Ukena D, Chanez P, Dent G, Chung KF, Barnes PJ: Beta-adrenergic receptors on eosinophils: binding and functional studies. Am Rev Respir Dis 141:1446 (1990).
5. Pedersen B, Dahl R, Larsen BB, Venge P: The effects of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein and serum eosinophil protein X. Allergy 48:377 (1993).
6. Seldon PM, Barnes PJ, Giembycz MA: Phosphodiesterase IV inhibitors and β2-adrenoreceptor agonists suppress lipopolysaccharide-induced tumour necrosis factor-generation by human peripheral blood monocytes. Br J Pharmacol 112:215P (1994).
7. Bishopric NH, Cohen HJ, Lefkowitz RJ: Beta adrenergic receptors in lymphocyte subpopulations. J Allergy Clin Immunol 65:29 (1980).
8. Conolly ME, Greenacre JK: The lymphocyte b-adrenoreceptor in normal subjects and patients with asthma: the effect of different forms of treatment on receptor function. J Clin Invest 58:1307 (1976).
9. Feldman RD, Hunninghake GW, McArdle WL: β2 - adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J Immunol 139:3355 (1987)
10. Oddera S, Silvestri M, Scarso L, Testi R, Rossi GA: Salmeterol inhibits the allergen-induced mononuclear cell proliferation and downregulates GM-CSF release and HLA-DR expression by monocytes. Pulmon Pharmacol 10:43 (1997).
11. 2-adrenoceptor agonist: fenoterol. J Asthma 35(5):401 (1998).
12. Wyllie AH, Kerr JF, Currie AR: Cell death: the significance of apoptcsis. Int Rev Cytol 68:251 (1980).
13. Arends MJ, Morris RG, Wyllie AH: Apoptosis. The role of endonuclease. Am J Pathol 136:593 (1990).
14. McConkey DJ, Orrenius S, Jondal M: Cellular signalling in programmed cell death (apoptosis). Immunol Today 11:120 (1990).
15. McConkey DJ, Orrenius S, Jondal M: Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol 145:1227 (1990).
16. Johnson KW, Davis BH, Smith KA: cAMP antagonizes interleukin 2-promoted T cell cycle progression at a discrete point in early G1. Proc Natl Acad Sci USA 85:6072 (1988).
17. Rossi GA, Zocchi E, Sacco O, Balbi B, et al: Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reaction. Role of HLA-DR antigens. Am Rev Respir Dis 133:78 (1986).
18. Burastero SE, Fenoglio D, Crimi E, Brusasco V, Rossi GA: Frequency of allergen-specific T-lymphocytes in blood and bronchial response to allergen in asthma. J Allergy Clin Immunol 91:1075 (1993).
19. Anderson KL, Anderson G, Michell RH, Jenkinson EJ, Owen JJT: Intracellular signaling pathways involved in the induction of apoptosis in immature T lymphocytes. J Immunol 156:4083 (1996).
20. Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB: TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immumol 154:1634 (1995).
21. Wag T, Sheppard JK, Foker JE: Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis. Science 201:155 (1978).
22. Oddera S, Silvestri M, Testi R, Rossi GA: Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation. Respiration 65:199 (1998).
23. Hall IP: β2-adrenoceptor polymorphisms: are they clinically important? Thorax 51:351 (1996).
24. Mary D, Aussel C, Ferrua B, Fehlmann M: Regulation of interleukin-2 synthesis by cAMP in human T-cells. J Immunol 139:1179 (1987).
25. Kahn MM, Sansoni P, Silverman ED, Engleman EG, Melmon KL: Beta-adrenergic receptors on human suppressor, helper and cytolytic lymphocytes. Biochem Pharmacol 35:1137 (1986).
26. Andersson U, Andersson J, Lindfors A, Wagner K, Møller G, Heusser CH: Simultaneous production of interleukin 2, interleukin 4 and interferon-γ by activated human blood lymphocytes. Eur J Immunol 20: 1591 (1990).
27. + precursor stage. Nature 334:620 (1988).
28. Hoshi S, Furatani-Seiki M, Seto M, Tada T, Asano Y: Prevention of TCR-mediated apoptosis by the elevation of c AMP. Int Immunol 6:1081 (1994).
29. Newman SP, Miller AB, Lennard-Jones TR, Moren F, Clarke SW: Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax 39: 935 (1984).
30. Newman SP: Therapeutic aerosols. In Aerosol and the Lung in Clinical and Experimental Aspects (Clarke SW, Pavia D, editors). Butterworths, London, 1984, pp. 197-224.
31. Kerrebijn KF: Beta agonists. In Asthma: Its Pathology and Treatment (Kaliner MA, Barnes PJ, Persson CGA, editors). Marcel Dekker Inc., New York, 1991, pp. 523-545.
32. Masclans JR, Barberà JA, MacNee W, Pavia J, Piera C, Lomena F, Chung KF, Roca J, Rodriguez-Roisin R: Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. Am J Respir Crit Care Med 149:529 (1996).
33. Kahn MM, Sansoni P, Silverman ED, Engleman EG, Melmon KL: Beta-adrenergic receptors on human suppressor, helper and cytolytic lymphocytes. Bioclicm Pharmacol 35:1137 (1986).
34. Taylor IK, O'Shaughnessy KM, Choudry NB, Adachi M, Palmer JBD, Fuller RW: A comparative study in atopic subject with asthma of effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity and increase in urinary leukotriene E4 excretion. J Allergy Clin Immunol 89:574 (1992).
35. Laitinen LA, Laitinen A, Haahtela T: A comparative study of the effects of inhaled corticosteroid, budesonide, and of a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 90:32 (1992).
36. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walter EH: Effects of eight weeks of treatment with salmeterol on bronchoalveolar lavage on inflammatory indices in asthmatics. Am J Respir Crit Care Med 150:1006 (1994).